Buprenorphine
The active medication category used for opioid-use disorder treatment and craving/withdrawal stabilization.
The active medication category used for opioid-use disorder treatment and craving/withdrawal stabilization.
A daily buprenorphine-naloxone medication option for opioid-use disorder.
A monthly injectable buprenorphine option for eligible patients who are already stabilized.
Buprenorphine can be very helpful, but it has to be started thoughtfully. If someone recently used fentanyl, heroin, oxycodone, hydrocodone, Percocet, Vicodin, codeine, OxyContin, or another opioid, the provider needs to understand timing, symptoms, prior buprenorphine experience, overdose history, and whether withdrawal has started.
Starting too early can make withdrawal feel abruptly worse. Waiting too long can leave someone uncomfortable, at risk of relapse, or unsafe. The first visit balances symptom relief with safety, especially when fentanyl exposure makes withdrawal timing less predictable.
Choose telehealth or local care when appropriate, share urgent timing needs, and bring medication, insurance, and pharmacy information.
Review opioid use, withdrawal symptoms, medical history, mental health, medication safety, and recovery goals without judgment.
If eligible, medication can be planned with education, pharmacy coordination, follow-up timing, and safety guidance.
Follow-up visits review cravings, side effects, dose stability, testing, relapse risk, counseling, and longer-term recovery needs.
Recent fentanyl, heroin, prescription opioid, or mixed substance use changes the start plan and follow-up timing.
Symptoms help determine whether medication timing is safe and whether dose adjustment may be needed later.
Pregnancy questions, liver disease, breathing problems, sedation risk, seizure history, pain needs, and current prescriptions all matter.
Work, family, transportation, housing, counseling, privacy, and pharmacy access can make the plan easier or harder to keep.
Hydrocodone, Vicodin, Percocet, codeine, and OxyContin are opioid pain medications. They can be involved in opioid-use disorder, but they are not medications used to treat opioid-use disorder. FDA-approved medications for opioid-use disorder include buprenorphine, methadone, and naltrexone. Nao Medical focuses on office-based buprenorphine and naltrexone/VIVITROL pathways, plus Sublocade review when appropriate.
Suboxone
A daily buprenorphine-naloxone option that can support outpatient stabilization when clinically appropriate.
Sublocade
A monthly injectable buprenorphine option for eligible patients already stabilized on buprenorphine.
VIVITROL
Monthly injectable naltrexone that requires opioid-free planning before opioid relapse-prevention use.
Methadone
An effective FDA-approved OUD medication usually provided through opioid treatment programs; referral may be appropriate.
Buprenorphine treatment is not one-size-fits-all. Early care often focuses on withdrawal relief, cravings, medication tolerance, overdose prevention, and getting through the first days without returning to unsafe opioid use. Once symptoms become more stable, follow-up can shift toward work routines, family trust, counseling, sleep, mood, and reducing situations that trigger relapse.
Some patients stay on medication for a long time because it keeps them safer and more functional. Others eventually ask about dose changes or tapering. That decision should be based on stability, overdose risk, support, prior relapse history, mental health, and timing rather than pressure or shame.
Visits may be closer together while withdrawal symptoms, cravings, dose response, side effects, and pharmacy access are still changing.
Once symptoms are steadier, care can focus on counseling, work routines, family trust, sleep, mental health, and relapse prevention.
Longer-term care reviews medication fit, refill timing, testing needs, insurance changes, and whether injectable options make sense.
Dose changes, missed doses, relapse, travel, surgery, pregnancy questions, or new medications should be discussed before the plan is altered.
Vomiting, dehydration, confusion, uncontrolled symptoms, or medical instability may need emergency or inpatient care.
Recent overdose, heavy fentanyl exposure, mixed sedative use, or loss of consciousness needs a stronger safety plan.
Suicidal thoughts, psychosis, severe agitation, or inability to stay safe needs urgent mental-health support.
Some patients do better with methadone through an opioid treatment program, especially when daily structure is needed.
Bronx
932 E 174th St, Bronx, NY 10460
A Bronx access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in West Farms, Crotona Park East, and nearby Bronx neighborhoods.
View local medication support Get directionsQueens
37-15 23rd Ave, Astoria, NY 11105
A Queens access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Astoria, Ditmars, East Elmhurst, and nearby Queens neighborhoods.
View local medication support Get directions
Bronx
2063A Bartow Ave, Bronx, NY 10475
A Bronx access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Co-op City, Pelham Bay, Baychester, and nearby Bronx neighborhoods.
View local medication support Get directions
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
A Brooklyn access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Crown Heights, Prospect Heights, and nearby Brooklyn neighborhoods.
View local medication support Get directions
Long Island
232 W Old Country Rd, Hicksville, NY 11801
A Long Island access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Hicksville, Plainview, Bethpage, and nearby Nassau County communities.
View local medication support Get directions
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
A Queens access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Jackson Heights, Elmhurst, Corona, and nearby Queens neighborhoods.
View local medication support Get directions
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
A Queens access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Jamaica, Briarwood, Richmond Hill, and nearby Queens neighborhoods.
View local medication support Get directions
Queens
30-07 36th Ave, Astoria, NY 11106
A Queens access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Long Island City, Astoria, Sunnyside, and nearby Queens neighborhoods.
View local medication support Get directions
Long Island
135 Mineola Blvd, Mineola, NY 11501
A Long Island access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Mineola, Garden City, Westbury, and nearby Nassau County communities.
View local medication support Get directions
Manhattan
259 1st Ave, New York, NY 10003
A Manhattan access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in StuyTown, East Village, Gramercy, and nearby Manhattan neighborhoods.
View local medication support Get directions
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
A Brooklyn access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Williamsburg, Greenpoint, Bushwick, and nearby Brooklyn neighborhoods.
View local medication support Get directionsWhat patients say about Nao Medical
Easy to book and the care team explained the next steps clearly.
Much smoother than bouncing between labs, urgent care, and paperwork.
Staff was kind, fast, and very clear about what to expect.
The visit felt organized from check-in through follow-up.
They helped me figure out coverage and scheduling without the usual hassle.
Clean clinic, friendly team, and a much better experience than I expected.